In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease

.noscript-container { margin: 0 auto; width: 400px; text-align: center; margin-top: 150px; }

protocols.io requires JavaScript to be enabled in the browser.